Clinical Trials Browser

Carcinoma, Neuroendocrine × surufatinib × Endocrine × Clear all

NCT05747729 2023-02-28

A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.

Phase 1/2 Unknown

Carcinoma, Neuroendocrine

NCT05627427 2022-11-25

Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

Phase 2 Unknown

EndocrineGastrointestinal

Pancreatic Neoplasms, Carcinoma, Neuroendocrine